We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
OGE icon
526
OGE Energy
OGE
$9.75B
$1.06M 0.02%
26,698
-889
-3% -$33.7K
2022 Q3
1 quarter
SYK icon
527
Stryker
SYK
$108B
$1.03M 0.02%
4,222
-4,703
-53% -$1.07M
2022 Q2
2 quarters
HPP icon
528
Hudson Pacific Properties
HPP
$659M
$1.03M 0.02%
15,064
-46,974
-76% -$3.49M
2021 Q1
7 quarters
LEN.B icon
529
Lennar Class B
LEN.B
$17.8B
$1.01M 0.02%
14,222
-4,974
-26% -$323K
2022 Q2
2 quarters
NHI icon
530
National Health Investors
NHI
$3.22B
$1.01M 0.02%
19,268
-105,051
-85% -$5.76M
2022 Q2
2 quarters
MNK
531
DELISTED
Mallinckrodt plc
MNK
$1M 0.02%
+129,376
New +$1.45M
2022 Q4
0 quarters
MRUS icon
532
DELISTED
Merus
MRUS
$995K 0.02%
64,300
-12,816
-17% -$226K
2022 Q1
3 quarters
SLB icon
533
SLB Ltd
SLB
$72.4B
$978K 0.02%
18,285
-609
-3% -$30.3K
2022 Q3
1 quarter
CCL icon
534
PUT
Carnival Corporation Ltd
CCL
$35.9B
$973K 0.02%
1,226,000
+220,000
+22% +$1.9M
2021 Q3
5 quarters
EQIX icon
535
Equinix
EQIX
$101B
$970K 0.02%
1,481
-885
-37% -$547K
2022 Q2
2 quarters
RDNW icon
536
RideNow Group
RDNW
$188M
$970K 0.02%
150,000
– –
2022 Q2
2 quarters
EPR icon
537
EPR Properties
EPR
$4.2B
$965K 0.02%
25,594
-5,395
-17% -$210K
2021 Q4
4 quarters
DAWN icon
538
DELISTED
Day One Biopharmaceuticals
DAWN
$946K 0.02%
43,936
+6,936
+19% +$142K
2022 Q3
1 quarter
TNDM icon
539
Tandem Diabetes Care
TNDM
$1.16B
$941K 0.02%
20,935
-5,695
-21% -$258K
2022 Q1
3 quarters
HWEL
540
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$941K 0.02%
94,525
-925
-1% -$9.09K
2021 Q4
4 quarters
IVCP icon
541
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$939K 0.02%
92,674
-907
-1% -$9.12K
2022 Q2
2 quarters
ROCL icon
542
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$937K 0.02%
92,674
-907
-1% -$9.09K
2022 Q1
3 quarters
ACAH
543
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$929K 0.02%
92,674
-907
-1% -$9K
2021 Q4
4 quarters
DTIL icon
544
Precision BioSciences
DTIL
$168M
$925K 0.02%
25,908
+9,491
+58% +$375K
2022 Q2
2 quarters
GTHX icon
545
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$893K 0.02%
+164,374
New +$1.38M
2022 Q4
0 quarters
NVNO icon
546
enVVeno Medical
NVNO
$5.54M
$863K 0.02%
4,833
+555
+13% +$113K
2022 Q1
3 quarters
OCUL icon
547
Ocular Therapeutix
OCUL
$1.59B
$860K 0.02%
305,953
+82,887
+37% +$274K
2022 Q1
3 quarters
RLAY icon
548
Relay Therapeutics
RLAY
$3.8B
$852K 0.02%
+57,000
New +$1.09M
2022 Q4
0 quarters
RIGL icon
549
Rigel Pharmaceuticals
RIGL
$881M
$849K 0.02%
56,614
+28,000
+98% +$257K
2022 Q1
3 quarters
MDU icon
550
MDU Resources
MDU
$3.92B
$845K 0.02%
73,237
-249,311
-77% -$2.8M
2022 Q3
1 quarter
20 21
22
23 24

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.